Cocrystal Pharma Stock Buy Hold or Sell Recommendation
| COCP Stock | USD 1.64 0.03 1.80% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Cocrystal Pharma is 'Sell'. A buy or sell recommendation provided by Macroaxis is an automated analysis based on historical performance and your stated risk tolerance. It serves as guidance on whether to purchase or sell Cocrystal Pharma within the specified time frame.
Check out Cocrystal Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide. Note, we conduct extensive research on individual companies such as Cocrystal and provide practical buy, sell, or hold advice based on investors' constraints. Cocrystal Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Cocrystal |
Execute Cocrystal Pharma Buy or Sell Advice
The Cocrystal recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Cocrystal Pharma. Macroaxis does not own or have any residual interests in Cocrystal Pharma or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Cocrystal Pharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Cocrystal Pharma Trading Alerts and Improvement Suggestions
| Cocrystal Pharma had very high historical volatility over the last 90 days | |
| Cocrystal Pharma may become a speculative penny stock | |
| Cocrystal Pharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (17.98 M) with loss before overhead, payroll, taxes, and interest of (14.77 M). | |
| Cocrystal Pharma currently holds about 51.03 M in cash with (14.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.28, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Cocrystal Pharma has a frail financial position based on the latest SEC disclosures | |
| Roughly 32.0% of the company shares are held by company insiders |
Cocrystal Pharma Returns Distribution Density
The distribution of Cocrystal Pharma's historical returns is an attempt to chart the uncertainty of Cocrystal Pharma's future price movements. The chart of the probability distribution of Cocrystal Pharma daily returns describes the distribution of returns around its average expected value. We use Cocrystal Pharma price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Cocrystal Pharma returns is essential to provide solid investment advice for Cocrystal Pharma.
| Mean Return | 0.02 | Value At Risk | -6.32 | Potential Upside | 14.85 | Standard Deviation | 8.27 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Cocrystal Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Cocrystal Pharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Cocrystal Pharma or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Cocrystal Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Cocrystal stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.08 | |
β | Beta against Dow Jones | 0.60 | |
σ | Overall volatility | 8.27 | |
Ir | Information ratio | 0.01 |
Cocrystal Pharma Volatility Alert
Cocrystal Pharma is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Cocrystal Pharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Cocrystal Pharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Cocrystal Pharma Fundamentals Vs Peers
Comparing Cocrystal Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Cocrystal Pharma's direct or indirect competition across all of the common fundamentals between Cocrystal Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Cocrystal Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Cocrystal Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Cocrystal Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Cocrystal Pharma to competition |
| Fundamentals | Cocrystal Pharma | Peer Average |
| Return On Equity | -0.86 | -0.31 |
| Return On Asset | -0.52 | -0.14 |
| Current Valuation | 5.85 M | 16.62 B |
| Shares Outstanding | 10.17 M | 571.82 M |
| Shares Owned By Insiders | 31.85 % | 10.09 % |
| Shares Owned By Institutions | 6.99 % | 39.21 % |
| Number Of Shares Shorted | 14.37 K | 4.71 M |
| Price To Earning | 193.33 X | 28.72 X |
| Price To Book | 1.34 X | 9.51 X |
| Price To Sales | 92.45 X | 11.42 X |
| Gross Profit | (14.77 M) | 27.38 B |
| EBITDA | (19.37 M) | 3.9 B |
| Net Income | (17.98 M) | 570.98 M |
| Cash And Equivalents | 51.03 M | 2.7 B |
| Cash Per Share | 6.28 X | 5.01 X |
| Total Debt | 1.85 M | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 18.34 X | 2.16 X |
| Book Value Per Share | 1.25 X | 1.93 K |
| Cash Flow From Operations | (14.67 M) | 971.22 M |
| Short Ratio | 0.55 X | 4.00 X |
| Earnings Per Share | (1.84) X | 3.12 X |
| Target Price | 8.33 | |
| Number Of Employees | 12 | 18.84 K |
| Beta | 2.35 | -0.15 |
| Market Capitalization | 16.99 M | 19.03 B |
| Total Asset | 31.26 M | 29.47 B |
| Retained Earnings | (315.91 M) | 9.33 B |
| Working Capital | 25.83 M | 1.48 B |
| Current Asset | 6.75 M | 9.34 B |
| Current Liabilities | 3.15 M | 7.9 B |
| Net Asset | 31.26 M |
Note: Acquisition by Japour Anthony J of 13567 shares of Cocrystal Pharma at 2.67 subject to Rule 16b-3 [view details]
Cocrystal Pharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Cocrystal . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Cocrystal Pharma Buy or Sell Advice
When is the right time to buy or sell Cocrystal Pharma? Buying financial instruments such as Cocrystal Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Cocrystal Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Utilities ETFs Thematic Idea Now
Utilities ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Utilities ETFs theme has 13 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Cocrystal Stock Analysis
When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.